ROBERT S. WEINSTEIN, MD
Osteopathic Medicine at Markham St, Little Rock, AR
License number
Arkansas E-0330
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
4301 W Markham St #783, Little Rock, AR 72205
Phone
(501) 686-8000
Organization information
See more information about ROBERT S. WEINSTEIN at bizstanding.comStavros C. Manolagas
4301 W Markham St, Little Rock, AR 72205
Industry:
Physician Endocrinologist
Doing business as:
Stavros C Manolagas - Vitaly Kantorovich MD<br>Stavros C Manolagas MD<br>Stavros C Manolagas - Robert S Weinstein MD
Phone:
(501) 296-1220 (Phone), (501) 686-7000 (Phone)
Director:
Stabros Manolagas Director, inactive
Categories:
Internal Medicine Physicians & Surgeons, Physicians & Surgeons, Endocrinology & Metabolism Physicians & Surgeons
Professional information
See more information about ROBERT S. WEINSTEIN at trustoria.com
Dr. Robert S Weinstein, Little Rock AR - MD (Doctor of Medicine)
Dr. Robert S Weinstein, Little Rock AR - MD (Doctor of Medicine)
Specialties:
Endocrinology, Diabetes & Metabolism, Endocrinology & Metabolism
Address:
UAMS Diabetic Endocrinlgy Clnc
4301 W Markham St SUITE 2, Little Rock 72205
(501) 296-1220 (Phone)
4301 W Markham St SUITE 2, Little Rock 72205
(501) 296-1220 (Phone)
Certifications:
Diabetes, Metabolism & Endocrinology, 1975, Internal Medicine, 1973
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Illinois At Chicago / College of Medicine
Graduated: 1970
Michael Reese Hospital and Medical Center
University Of Miami Hospital
University of Illinois At Chicago / College of Medicine
Graduated: 1970
Michael Reese Hospital and Medical Center
University Of Miami Hospital
Vitro And In Vivo Models For Screening Compounds To Prevent Glucocorticoid-Induced Bone Destruction
Vitro And In Vivo Models For Screening Compounds To Prevent Glucocorticoid-Induced Bone Destruction
US Patent:
6660468, Dec 9, 2003
Filed:
Oct 7, 1999
Appl. No.:
09/413958
Inventors:
Stavros C. Manolagas - Little Rock AR
Robert L. Jilka - Little Rock AR
Robert S. Weinstein - Little Rock AR
Teresita Bellido - Little Rock AR
Robert L. Jilka - Little Rock AR
Robert S. Weinstein - Little Rock AR
Teresita Bellido - Little Rock AR
Assignee:
Board of Trustees of the University of Arkansas - Little Rock AR
International Classification:
C12Q 100
US Classification:
435 4, 435 71
Abstract:
The present invention demonstrates that glucocorticoid-induced bone disease is due to changes in the birth and death rate of bone cells using a murine model of glucocorticoid excess as well as bone biopsy specimens obtained from patients with glucocorticoid-induced osteoporosis. This invention demonstrates that glucocorticoid administration increases apoptosis of mature osteoblasts and osteocytes and decreases bone formation rate and bone mineral density accompanied by defective osteoblastogenesis and osteoclastogenesis in the bone marrow.
In Vitro And In Vivo Models For Screening Compounds To Prevent Glucocorticoid-Induced Bone Destruction
In Vitro And In Vivo Models For Screening Compounds To Prevent Glucocorticoid-Induced Bone Destruction
US Patent:
2004024, Dec 9, 2004
Filed:
Dec 8, 2003
Appl. No.:
10/730751
Inventors:
Stavros Manolagas - Little Rock AR, US
Robert Jilka - Little Rock AR, US
Robert Weinstein - Little Rock AR, US
Teresita Bellido - Little Rock AR, US
Robert Jilka - Little Rock AR, US
Robert Weinstein - Little Rock AR, US
Teresita Bellido - Little Rock AR, US
Assignee:
Board of Trustees of the University of Arkansas
International Classification:
C12Q001/00
US Classification:
435/004000
Abstract:
The present invention demonstrates that glucocorticoid-induced bone disease is due to changes in the birth and death rate of bone cells using a murine model of glucocorticoid excess as well as bone biopsy specimens obtained from patients with glucocorticoid-induced osteoporosis. This invention demonstrates that glucocorticoid administration increases apoptosis of mature osteoblasts and osteocytes and decreases bone formation rate and bone mineral density accompanied by defective osteoblastogenesis and osteoclastogenesis in the bone marrow.
Methods Of Screening For Apoptosis-Controlling Agents For Bone Anabolic Therapies And Uses Thereof
Methods Of Screening For Apoptosis-Controlling Agents For Bone Anabolic Therapies And Uses Thereof
US Patent:
2004022, Nov 11, 2004
Filed:
Dec 22, 2003
Appl. No.:
10/743360
Inventors:
Stavros Manolagas - Little Rock AR, US
Robert Jilka - Little Rock AR, US
Robert Weinstein - Little Rock AR, US
Teresita Bellido - Little Rock AR, US
Robert Jilka - Little Rock AR, US
Robert Weinstein - Little Rock AR, US
Teresita Bellido - Little Rock AR, US
International Classification:
A61K038/29
US Classification:
514/012000
Abstract:
The invention as disclosed provides a method to increase bone mass without compromising bone strength or quality, through the administration to a host of a compound that binds to the estrogen or androgen receptor without causing hormonal transcriptional activation.
Method And Compositions For Increasing Bone Mass
Method And Compositions For Increasing Bone Mass
US Patent:
2005002, Feb 3, 2005
Filed:
Apr 21, 2004
Appl. No.:
10/829028
Inventors:
Stavros Manolagas - Little Rock AR, US
Robert Jilka - Little Rock AR, US
Robert Weinstein - Little Rock AR, US
Teresita Bellido - Little Rock AR, US
Donald Bodenner - Little Rock AR, US
Stavroula Kousteni - Little Rock AR, US
Robert Jilka - Little Rock AR, US
Robert Weinstein - Little Rock AR, US
Teresita Bellido - Little Rock AR, US
Donald Bodenner - Little Rock AR, US
Stavroula Kousteni - Little Rock AR, US
Assignee:
The Board of Trustees of the University of Arkansas - Little Rock AR
International Classification:
G01N033/53, G01N033/567, A61K031/56
US Classification:
435007200, 514169000
Abstract:
The invention as disclosed provides a method to increase bone mass without compromising bone strength or quality, through the administration to a host of a compound that binds to the estrogen or androgen receptor without causing hormonal transcriptional activation.